Výsledky vyhledávání - "Marie Noëlle Lacassagne"

Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease

Autor: Delphine Lebon, Adèle Dujardin, Alexis Caulier, Magalie Joris, Amandine Charbonnier, Bérengère Gruson, Marine Quint, Sandrine Castelain, Catherine François, Marie-Noëlle Lacassagne, Nicolas Guillaume, Jean-Pierre Marolleau, Pierre Morel

Publikováno v: Leukemia Research. 125:107005

Steroid-refractory graft-versus-host disease (SR-GVHD) is a challenging complication of allogeneic hematopoietic stem cell transplantation, and leads to high morbidity and mortality rates. The orally administered, selective Janus-associated kinase 1/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33cec9b4d72a147fe3f177a554ff310
https://doi.org/10.1016/j.leukres.2022.107005

Zobrazit plný text záznamu

Mutualisation des outils de qualité pour les cellules CAR-T : recommandations de la Société francophone de greffe de moelle et thérapie cellulaire (SFGM-TC)

Autor: Remy Dulery, Jean-Louis Beaumont, Agnes Perrin, Sylvie Carnoy, Cécile Gibault-Joffe, Virginie Ader, Nathalie Contentin, Sophie Plaza-Milhe, Nathalie Fegueux, Philippe Lewalle, Christine Giraud, Marie-Noëlle Lacassagne, Thi Ngoc Phuong Huynh, Alexandre Carpentier, Agnès Bonnin, Marie-Agnès Guerout-Verite, Ibrahim Yakoub-Agha

Publikováno v: Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2020, 107, pp.S193-S201. ⟨10.1016/j.bulcan.2020.10.001⟩
Bulletin du Cancer, 2020, 107, pp.S193-S201. ⟨10.1016/j.bulcan.2020.10.001⟩

International audience; CAR T-cells are anti-cancer immunocellular therapy drugs that involve reprogramming the patient's T-cells using a transgene encoding a chimeric antigen receptor (CAR). Although CAR T-cells are cellular therapies, the organizat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8144ee05c2d384b866352c6c817959e9
https://hal.archives-ouvertes.fr/hal-03493426

Zobrazit plný text záznamu

Negative MRD at Day 100 after Allogenic Hematopoietic Stem Cell Transplant (HSCT): The Grail to Reach in Acute Myeloid Leukemia (AML)

Autor: Judith Desoutter, Véronique Harrivel, Alice Marceau, Delphine Lebon, Alexis Caulier, Jean-Pierre Marolleau, Marine Quint, Nicolas Duployez, Amandine Charbonnier, Lavinia Merlusca, Magalie Joris, Thomas Boyer, Lydia Montes, Marie-Noëlle Lacassagne, Audrey Da Rocha, Mathieu Sage, Nicolas Guillaume

Publikováno v: Blood. 138:2928-2928

INTRODUCTION : HSCT remains the best curative treatment in eligible AML patients with adverse or intermediate cytogenetics according to the ELN classification, and for those with unfavorable molecular markers at diagnostic or with a positive measurab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d80de1373a088e90dcc68c5fb54c36f3
https://doi.org/10.1182/blood-2021-145523

Zobrazit plný text záznamu

Cryopreservation and thawing of hematopoietic stem cell CD34-induced apoptosis through caspase pathway activation: Key role of granulocytes

Autor: Véronique Harrivel, Jean Pierre Marolleau, Marie-Noëlle Lacassagne, Judith Desoutter, Christèle Ossart, Aline Regnier

Publikováno v: Cytotherapy
Cytotherapy, Elsevier, 2019, 21, pp.612-618. ⟨10.1016/j.jcyt.2019.04.004⟩

Introduction Cell damage inescapably occurs during both the freezing and the thawing graft processes for autologous hematopoietic stem cell (HSC) transplantation. To estimate HSC injury, a quality control is performed including: (i) CD34+ quantificat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c07cb747abdd18384a47f1ad4ef75668
https://pubmed.ncbi.nlm.nih.gov/31056424

Zobrazit plný text záznamu

Immunomodulation with azacytidine and donor lymphocyte infusion following sequential conditioning allogenic stem cell transplantation improves outcome of unfavorable AML

Autor: Delphine Lebon, Magalie Joris, Amandine Charbonnier, Marie-Noëlle Lacassagne, Pierre Morel, Jean-Pierre Marolleau, Alexis Caulier, Nicolas Guillaume, Berengere Gruson, Loïc Garçon, Caroline Delette

Publikováno v: Blood
Blood, 2019, 134 (1 (supplement)), ⟨10.1182/blood-2019-131314⟩

Background : Patients with acute myeloid leukemia in relapse or refractory to induction therapy have dismal prognosis. Response rates to common salvage regimens are low and allogenic hematopoietic stem cell transplantation is the only curative option

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5686603be481cd910148bae090fbd2f6
https://hal-u-picardie.archives-ouvertes.fr/hal-03605009

Zobrazit plný text záznamu

Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Autor: Thierry Guillaume, John De Vos, Xavier Poiré, Audrey Cras, Marie-Agnès Guerout-Verite, Anne-Lise Ménard, Sylvain Lamure, Jean El Cheikh, Marie-Noëlle Lacassagne, Ibrahim Yakoub-Agha, Catherine Letellier, Etienne Baudoux, Boris Calmels, Etienne Daguindau, Jacques-Olivier Bay

Publikováno v: Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (1), pp.S35-S39
Bulletin du Cancer, 2019, 106 (1), pp.S35-S39. ⟨10.1016/j.bulcan.2018.10.002⟩
Bulletin du cancer, Vol. 106, no. Suppl 1, p. S35-S39 (2019)

Donor lymphocyte infusion (DLI) can be proposed to treat or prevent the relapse of malignant hemopathies following allogeneic stem cell transplantation. The efficiency has been mainly reported in the treatment of CML and low-grade lymphomas while the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5fc4ff1c4342a47f92b9fbd0bd81026
https://hal.archives-ouvertes.fr/hal-02055937

Zobrazit plný text záznamu

Fast CMV and EBV Reactivations after Ruxolitinib for Graft-Versus-Host Disease Treatment

Autor: Delphine Lebon, Marie-Noëlle Lacassagne, Berengere Gruson, Sandrine Castelain, Magalie Joris, Dujardin Adèle, Pierre Morel, Jean-Pierre Marolleau, Marine Quint, Amandine Charbonnier, Alexis Caulier

Publikováno v: Blood
Blood, 2019, 134 (1), ⟨10.1182/blood-2019-123283⟩

Introduction: Corticosteroid-refractory graft-versus-host disease (GVHD) remains a serious complication of hematopoietic stem cell transplantation (HSCT) with high morbidity and mortality rates. Unfortunately, no standard therapy exists for this sett

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f328e98e28bd33d6120b5aafb9990b2d
https://hal-u-picardie.archives-ouvertes.fr/hal-03592188

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání